Stock Events

Stock Events

Contineum Therapeutics (CTNM) Q2 2025 Earnings

14MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.62

-0.53

-0.44

-0.35

Details

Expected EPS

-0.565

Actual EPS

-0.62

Surprise EPS

-0.06

Surprise Percent

+9.73%

Description

Contineum Therapeutics (CTNM) has reported earnings of -0.62 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.